Escalated BEACOPP

DRUG2 trials

Sponsors

Ospedale Santa Croce-Carle Cuneo, Cancer Institute WIA

Conditions

HODGKIN LYMPHOMAHodgkin's Lymphoma

Phase 2

Positron Emission Tomography (PET)-Adapted Chemotherapy In Advanced Hodgkin Lymphoma (HL)

Ospedale Santa Croce-Carle CuneoHODGKIN LYMPHOMA

Start: 2008-06-30End: 2015-10-31Target: 450Updated: 2015-10-19

Unknown Phase

Use of Interim PET Scan to Modify Therapy in Advanced Hodgkin's Lymphoma in Order to Improve Outcomes

CompletedNCT01304849

Cancer Institute WIAHodgkin's Lymphoma

Start: 2011-01-31End: 2013-09-30Updated: 2015-02-04

Related Papers

PET Radiomics Discriminate Among Different Lymphoma Sub-Types

Blood2024-11-051 citations

The Prognostic Value of MTV Is Retained in New Proposed SUV 4 Threshold: An International Comparison of Follicular and Hodgkin Patient Survival

Blood2024-11-05

Lesion Dissemination in Baseline PET/CT (D-MAX) and IPS Score Predict ABVD Treatment Outcome in PET-2 Negative Advanced-Stage Hodgkin Lymphoma Patients Enrolled in the Prospective GITIL/FIL HD0607 Trial

Blood2021-11-058 citations

Myocardial Metabolic Response Predicts Chemotherapy Curative Potential on Hodgkin Lymphoma: A Proof-of-Concept Study

Biomedicines2021-08-063 citations

BASELINE METABOLIC TUMOR VOLUME AND IPS PREDICT ABVD FAILURE IN ADVANCED‐STAGE HODGKIN LYMPHOMA WITH A NEGATIVE INTERIM PET SCAN AFTER 2 CHEMOTHERAPY CYCLES. A RETROSPECTIVE ANALYSIS FROM THE GITIL/FIL HD0607 TRIAL

Hematological Oncology2021-06-014 citations

Consolidation Radiotherapy Could Be Safely Omitted in Advanced Hodgkin Lymphoma With Large Nodal Mass in Complete Metabolic Response After ABVD: Final Analysis of the Randomized GITIL/FIL HD0607 Trial

Journal of Clinical Oncology2020-09-1858 citations

Early serum <scp>TARC</scp> reduction predicts prognosis in advanced‐stage <scp>Hodgkin</scp> lymphoma patients treated with a <scp>PET</scp> ‐adapted strategy

Hematological Oncology2020-06-3014 citations

Phase II study of interim PET-CT-guided response-adapted therapy in advanced Hodgkin's lymphoma.

2015-02-2022 citations